TY - JOUR
T1 - Emergent use of extracorporeal membrane oxygenation during pediatric cardiac catheterization
AU - Allan, Catherine K.
AU - Thiagarajan, Ravi R.
AU - Armsby, Laurie R.
AU - Del Nido, Pedro J.
AU - Laussen, Peter C.
PY - 2006/5/1
Y1 - 2006/5/1
N2 - Objectives: The goal of this study was to evaluate the utility of extracorporeal membrane oxygenation (ECMO) to resuscitate patients following critical cardiac events in the catheterization laboratory. Design: Retrospective review of medical records. Setting: Cardiac intensive care unit and cardiac catheterization laboratory at a tertiary care children's hospital. Patients: Pediatric patients cannulated emergently for ECMO in the cardiac catheterization laboratory (n = 22). Interventions: ECMO was initiated emergently in the cardiac catheterization laboratory for progressive hemodynamic deterioration due to low cardiac output syndrome or catheter-induced complications. Measurements and Main Results: Twenty-two patients were cannulated for ECMO in the catheterization laboratory between 1996 and 2004. Median age was 33 months (range 0-192), median weight 14.8 kg (2.4-75), and median duration of ECMO 84 hrs (2-343). Indications included catheter-induced complication (n = 14), severe low cardiac output syndrome (n = 7), and hypoxemia (n = 1). Three patients (14%) were cannulated in the catheterization laboratory before catheterization for low cardiac output or hypoxemia. During cannulation, 19 patients (86%) were receiving chest compressions; median duration of cardiopulmonary resuscitation was 29 mins (20-57). Eighteen patients (82%) survived to discharge (five of whom underwent cardiac transplantation) and four (18%) died. Of 19 patients who received cardiopulmonary resuscitation during cannulation, 15 (79%) survived to discharge and nine (47%) sustained neurologic injury. There was no significant difference between survivors and nonsurvivors in age, weight, duration of cardiopulmonary resuscitation or ECMO support, pH, or lactate levels. Conclusions: ECMO is a technically feasible and highly successful tool in the resuscitation of pediatric patients following critical events in the cardiac catheterization laboratory.
AB - Objectives: The goal of this study was to evaluate the utility of extracorporeal membrane oxygenation (ECMO) to resuscitate patients following critical cardiac events in the catheterization laboratory. Design: Retrospective review of medical records. Setting: Cardiac intensive care unit and cardiac catheterization laboratory at a tertiary care children's hospital. Patients: Pediatric patients cannulated emergently for ECMO in the cardiac catheterization laboratory (n = 22). Interventions: ECMO was initiated emergently in the cardiac catheterization laboratory for progressive hemodynamic deterioration due to low cardiac output syndrome or catheter-induced complications. Measurements and Main Results: Twenty-two patients were cannulated for ECMO in the catheterization laboratory between 1996 and 2004. Median age was 33 months (range 0-192), median weight 14.8 kg (2.4-75), and median duration of ECMO 84 hrs (2-343). Indications included catheter-induced complication (n = 14), severe low cardiac output syndrome (n = 7), and hypoxemia (n = 1). Three patients (14%) were cannulated in the catheterization laboratory before catheterization for low cardiac output or hypoxemia. During cannulation, 19 patients (86%) were receiving chest compressions; median duration of cardiopulmonary resuscitation was 29 mins (20-57). Eighteen patients (82%) survived to discharge (five of whom underwent cardiac transplantation) and four (18%) died. Of 19 patients who received cardiopulmonary resuscitation during cannulation, 15 (79%) survived to discharge and nine (47%) sustained neurologic injury. There was no significant difference between survivors and nonsurvivors in age, weight, duration of cardiopulmonary resuscitation or ECMO support, pH, or lactate levels. Conclusions: ECMO is a technically feasible and highly successful tool in the resuscitation of pediatric patients following critical events in the cardiac catheterization laboratory.
UR - http://www.scopus.com/inward/record.url?scp=33646895155&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646895155&partnerID=8YFLogxK
U2 - 10.1097/01.PCC.0000200964.88206.B0
DO - 10.1097/01.PCC.0000200964.88206.B0
M3 - Article
C2 - 16474257
AN - SCOPUS:33646895155
SN - 1529-7535
VL - 7
SP - 212
EP - 219
JO - Pediatric Critical Care Medicine
JF - Pediatric Critical Care Medicine
IS - 3
ER -